Successful completion of $13 million Placement
Released
Released
Announcement PDF
Successful completion of $13 million Placement
Launch of Security Purchase Plan (SPP) to raise approximately $2.5 million
Key Highlights:
• Strong support from institutional investors
• Funds to be applied towards development of Great White Project and advancement
of HPA Project
• Balance of funding for the Great White Project being progressed via discussions for
cornerstone investment at asset level
Andromeda Metals Limited (ASX: ADN) (Andromeda, the Company) is pleased to announce that it has
successfully undertaken a placement of new fully paid ordinary shares (Placement) raising approximately
$13 million before costs.
Firm commitments for 742.9 million new fully paid ordinary shares have been received from new institutional
and sophisticated investors (New Shares) at $0.0175 per New Share under the Placement.
The price of $0.0175 per New Share, represents a discount of:
• 16.7% to the previous closing price of $0.021 on Wednesday, 15 October 2025;
• and
• 9.8% to the 15 trading day volume weighted average price of $0.0194, calculated up to and
including Wednesday 15 October 2025.
Placement participants will also receive 3 free attaching options for every 5 New Shares allocated (New
Options), subject to issue of a prospectus and shareholder approval. Each New Option is exercisable at
$0.026 for a fully paid ordinary share, expiring 2 years from the date of issue and otherwise on the terms set
out in Annexure 1. Application will be made for quotation of New Options on ASX. If exercised, these New
Options will provide an additional $11.6 million in capital for the Company.
The Company is pleased by the strong support shown from these new investors and welcomes them as
shareholders.
The placement of New Shares will be issued in accordance with Andromeda’s placement capacity under
ASX Listing Rule 7.1 and Listing Rule 7.1A (with 361,189,503 shares coming under Listing Rule 7.1 and
381,667,640 shares coming within Listing Rule 7.1A). Shareholder approval will be sought for the issue of the
New Options at a General Meeting (to be scheduled).
Settlement of the Placement is scheduled to occur on Thursday 23 October 2025, with issue of the New
Shares under the Placement scheduled to occur on Friday 24 October 2025. New Options will only be issued
after shareholder approval is obtained.
Andromeda Metals Limited ASX: ADN
ASX Announcement
10/431 King William Street
Adelaide, SA 5000
Tel:+61 8 7089 9800
ir@andromet.com.au
17 October 2025
ABN
75 061 503 375
Bell Potter and Canaccord Genuity are Joint Lead Managers to the Placement and are entitled to a fee
of 6% on the funds raised, plus the issue of 13 million options on the same terms as the New Options.
Funds raised will be used towards the development of the Great White Project and advancement of HPA,
including early works, equipment procurement, product marketing (including HPA), general working
capital and costs of the capital raise.
In support of securing the balance of funding required for a final investment decision for Stage 1A+ of the
Great White Project, the Company is progressing discussions with a cornerstone investor for an investment
at the asset level. Finalisation of this process remains subject to due diligence, approvals and agreement
on terms.
Per the Company’s prior announcements1, A$90 million is required for Stage 1A+ capital expenditure and
working capital. Financing and cash reserving costs will be additional to the A$90m and include:
• Capitalised interest during development;
• Cash reserving (Debt Service Reserve Account and Cost Overrun); and
• Upfront fees for equity and debt.
Sarah Clarke, Andromeda’s Acting Chief Executive Officer said:
“This capital raise is a strategic step to accelerate the initial development of Stage 1A+ of the Great White
Project, whilst we progress discussions for a cornerstone investment at the asset level for both the Great
White Project and the HPA Project.
This will allow us to progress equipment procurement for the balance of the plant, commence site
preparation activities for Stage 1A+. In addition, marketing activities in support of the commercialisation of
our innovative high purity alumina technology will be undertaken, following completion of the scoping
study demonstrating market leading economics and the initiation of pilot scale testwork to generate
samples for customer engagement.
“The strong support for this Placement and the increased investor participation positions Andromeda well
to advance Stage 1A+ towards a final investment decision while also progressing development of the
exciting HPA opportunity.”
The trading halt can now be lifted.
Security Purchase Plan
The Company is pleased to offer all existing eligible shareholders on the Company’s share register at 7pm
(Sydney time) on 16 October 2025 with registered addresses in Australian or New Zealand the opportunity
to apply for New Shares and free attaching New Options by participating in the SPP.
The Company is targeting to raise approximately $2.5 million before costs through the SPP, with funds raised
to be used for the same purpose as described above.
The application for New Shares under the SPP will be capped at a maximum of $30,000 per eligible
shareholder, across all of their holdings.
The offer price of $0.0175 per New Share under the SPP will be the same as the issue price under the
Placement. This will allow eligible shareholders to increase their holding without paying brokerage or
1
Refer ADN ASX dated 29 April 2025 titled Quarterly Activities/Appendix 5B Cash Flow Report
transaction costs. Participants in the SPP will also receive 3 free attaching New Options for every 5 Shares
allocated, subject to the issue of a prospectus and shareholder approval at an upcoming general meeting.
The terms and conditions of the SPP will be set out in an Offer Booklet which will be released to ASX by way
of a separate announcement in due course. Participation in the SPP is optional and the Company reserves
the right to scale back any applications or accept a higher amount than the target amount (subject to
the ASX Listing Rules and ASIC Regulatory Guide 125).
The Joint Lead Managers will be entitled to a fee of 2% of funds raised under the SPP.
Capital Structure
The capital structure of the Company on successful completion of the Placement is expected to be as
follows:
Number of
Shares
Number of Quoted Options Number of
Unquoted Options
Number of
Performance
Rights
As at the date
of this
announcement
3,816,676,408
338,440,053 exercisable at
$0.0175 and expiry 30 Sep 27
60,238,882 31,692,000
293,461,554 exercisable at
$0.0195 expiring 2 years after
issue
To be issued
under the
Placement
742,857,143 458,714,286** exercisable at
$0.026 expiring 2 years after
issue
Nil Nil
To be issued
under SPP*
142,857,143 85,714,286 exercisable at
$0.026 expiring 2 years after
issue
Nil Nil
Total number
following
capital raise*
4,702,390,694 1,176,330,179 60,238,882 31,692,000
*assumes $2.5 million raised under the SPP ** includes broker options
Timetable
The indicative timetable for the capital raise is set out as follows:
Event Date
Record date for SPP Thursday 16 October 2025
Placement and SPP Announced Friday 17 October 2025
Settlement of Placement Thursday 23 October 2025
Allotment and Trading of New Shares under
Placement
Friday 24 October 2025
Opening Date for SPP Monday 27 October 2025
Closing Date for SPP Friday 14 November 2025
Announcement of results of SPP and issue SPP Shares Not later than noon on Friday 21
November 2025
Extraordinary General Meeting December 2025
Allotment and Trading of New Options (subject to
admission to quotation)
Following shareholder approval
Dates and times are indicative only and may be subject to change (subject to the requirements in the ASX
Listing Rules). Any material changes will be notified to ASX. All dates and times are references to AEST,
Australia time.
This announcement has been approved for release by the Board of Andromeda Metals Limited.
For more information about the Company and its projects, please visit our website,
www.andromet.com.au or contact:
Manager, Investor Relations & Corporate Affairs
Patrick Sinclair
T: 08 7089 9819
M: 0403 708 431
E: Patrick.Sinclair@andromet.com.au
FORWARD-LOOKING STATEMENTS
This document contains or may contain certain forward-looking statements and comments about future events, that are
based on Andromeda's beliefs, assumptions and expectations and on information currently available to management as
at the date of this document. Often, but not always, forward-looking statements can generally be identified by the use of
forward-looking words such as "may", "will", "expect", "plan", "believes", "estimate", "anticipate", "outlook", and "guidance", or
similar expressions. Such statements are only expectations or beliefs and are subject to inherent risks and uncertainties which
could cause actual values, results or performance achievements to differ materially from those expressed or implied in this
presentation. Where Andromeda expresses or implies an expectation or belief as to future events or results, such
expectation or belief is expressed in good faith and on a reasonable basis. No representation or warranty, express or implied,
is made by Andromeda that the matters stated in this presentation will in fact be achieved or prove to be correct. Except
as required by law, Andromeda undertakes no obligation to provide any additional or updated information or update any
forward-looking statements, whether on a result of new information, future events, results or otherwise. Readers are
cautioned against placing undue reliance on forward-looking statements. These forward-looking statements are not
guarantees of future performance and involve known and unknown risks, uncertainties, assumptions and other important
factors, many of which are beyond the control of Andromeda, the directors, and management of Andromeda.
Annexure 1 – Option Terms
The New Options (including the options to be issued to the brokers) are all in the same class and will
be issued on the following terms and conditions:
(a) Entitlement
Each Option entitles the holder to acquire by way of issue one Share on exercise of the
Option.
(b) Exercise Price
Subject to paragraph (h) below, the exercise price of the Options will be $0.026 (Exercise Price).
(c) Expiry Date
Each Option will expire at 5.00pm (AEST) 2 years after the date of issue. An Option not
exercised by the Expiry Date will automatically lapse at that time at that time.
(d) Exercise Period
The Options are exercisable at any time on or prior to the Expiry Date (Exercise Period).
(e) Notice of Exercise
A Notice of Exercise is only effective on and from the later of the date of receipt of the
Notice of Exercise and the date of receipt of the payment of the applicable Exercise Price
for each Option being exercised in cleared funds (Exercise Date).
A minimum of 100,000 Options may be exercised under each Notice of Exercise. If a
Shareholder holds less than 100,000 Options, all of the Options held by them must be
exercised in one Notice of Exercise.
(f) Timing of issue of Shares on exercise
As soon as practicable after the Exercise Date, the Company will:
(i) issue the number of Shares required under these terms and conditions in respect of
the number of Options specified in the Notice of Exercise and for which cleared
funds have been received by the Company; and
(ii) if admitted to the Official List at the time, apply for official quotation on ASX of
Shares issued on the exercise of the Options.
(g) Shares issued on exercise
Shares issued on exercise of the Options will rank equally in all respects with the then issued
Shares.
(h) Reconstruction of capital
If at any time the issued capital of the Company is reconstructed, all rights of a holder of
Options are to be changed in a manner consistent with the Corporations Act, the ASX
Listing Rules and any other applicable laws or regulations at the time of the reconstruction.
(i) Participation in new issues
There are no participation rights or entitlements inherent in the Options and holders will not
be entitled to participate in new issues of capital offered to Shareholders during the
currency of the Options without exercising the Options and unless Shares have been issued
in respect of the Options before the record date for determining entitlements to the issue.
(j) Change in Exercise Price
There will be no change to the applicable Exercise Price of an Option or the number of
Shares over which an Option is exercisable in the event of the Company making a pro
rata issue of Shares or other securities to the holders of Shares (other than for a Bonus
Issue).
(k) Bonus issue
If before the expiry of any Options, the Company makes a pro rata issue of Shares to
Shareholders for no consideration (Bonus Issue), the number of Shares over which an
Option is exercisable will be increased by the number of Shares which the holder would
have received if the Option had been exercised before the record date for the
Bonus Issue.
(l) Transferability
The Options are transferable and application will be made for quotation on ASX.
(m) Voting
Holders of Options have no voting rights until the Options are exercised and Shares
issued on exercise of those Options in accordance with the ASX Listing Rules.
Share your feedback
Discover